Profound weight loss associated with reboxetine use in a 44‐year‐old woman | Zendy

Lu T. Y.T. | Zendy; Kupa A. | Zendy; Easterbrook G. | Zendy; Mangoni A. A. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Profound weight loss associated with reboxetine use in a 44‐year‐old woman

Author(s) -

Lu T. Y.T.,

Kupa A.,

Easterbrook G.,

Mangoni A. A.

Publication year - 2005

Publication title -

british journal of clinical pharmacology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.216

H-Index - 146

eISSN - 1365-2125

pISSN - 0306-5251

DOI - 10.1111/j.1365-2125.2005.02407.x

Subject(s) - reboxetine , weight loss , body mass index , medicine , body weight , obesity , reuptake inhibitor , receptor , serotonin

We report a case of significant weight loss experienced by a 44‐year‐old Caucasian woman treated with reboxetine. She was treated with this drug at 12 mg daily for a total duration of 11 months. During the corresponding period her body mass index (BMI) decreased from a baseline of 21.4 kg m −2 to a low of 16.8 kg m −2 . Withdrawal of the drug led to a full recovery of her BMI. The strongest evidence linking reboxetine to this woman's weight loss laid in the fact that the re‐introduction of the drug subsequently caused a similar negative impact in her BMI.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research